{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T19:06:35Z","timestamp":1788980795678,"version":"build-2803163510"},"reference-count":28,"publisher":"China Science Publishing & Media Ltd.","issue":"7","content-domain":{"domain":["engine.scichina.com"],"crossmark-restriction":false},"short-container-title":["ABBS"],"published-print":{"date-parts":[[2024,7,1]]},"DOI":"10.3724\/abbs.2024045","type":"journal-article","created":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T06:42:06Z","timestamp":1717483326000},"page":"973-985","update-policy":"https:\/\/doi.org\/10.1360\/scp-crossmark-policy-page","source":"Crossref","is-referenced-by-count":6,"title":["FANCA facilitates G1\/S cell cycle advancement, proliferation, migration and invasion in gastric cancer"],"prefix":"10.3724","volume":"56","author":[{"given":"Wei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shantanu","family":"Baral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiannan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liuhua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daorong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2026","published-online":{"date-parts":[[2024,4,29]]},"reference":[{"key":"CITATION1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"Bray F","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 2018, 68: 394-424.","journal-title":"CA Cancer J Clin"},{"key":"CITATION2","doi-asserted-by":"publisher","first-page":"893","DOI":"10.3724\/abbs.2023038","volume":"55","author":"Cao Z","year":"2023","unstructured":"Cao Z, An L, Han Y, Jiao S, Zhou Z. The Hippo signaling pathway in gastric cancer. Acta Biochim Biophys Sin, 2023, 55: 893-903.","journal-title":"Acta Biochim Biophys Sin"},{"key":"CITATION3","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1136\/gutjnl-2019-320234","volume":"69","author":"Arnold M","year":"2020","unstructured":"Arnold M, Park JY, Camargo MC, Lunet N, Forman D, Soerjomataram I. Is gastric cancer becoming a rare disease? A global assessment of predicted incidence trends to 2035. Gut, 2020, 69: 823-829.","journal-title":"Gut"},{"key":"CITATION4","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1002\/ijc.28999","volume":"136","author":"Plummer M","year":"2015","unstructured":"Plummer M, Franceschi S, Vignat J, Forman D, de Martel C. Global burden of gastric cancer attributable to                          Helicobacter                          pylori. Int J Cancer, 2015, 136: 487-490.","journal-title":"Int J Cancer"},{"key":"CITATION5","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/nm.3850","volume":"21","author":"Cristescu R","year":"2015","unstructured":"Cristescu R, Lee J, Nebozhyn M, Kim KM, Ting JC, Wong SS, Liu J. Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes. Nat Med, 2015, 21: 449-456.","journal-title":"Nat Med"},{"key":"CITATION6","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.3724\/abbs.2023119","volume":"55","author":"Li S","year":"2023","unstructured":"Li S, Wei Y, Sun X, Liu M, Zhu M, Yuan Y, Zhang J. JUNB mediates oxaliplatin resistance via the MAPK signaling pathway in gastric cancer by chromatin accessibility and transcriptomic analysis. Acta Biochim Biophys Sin, 2023, 55: 1784-1796.","journal-title":"Acta Biochim Biophys Sin"},{"key":"CITATION7","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/nature11863","volume":"493","author":"Kottemann MC","year":"2013","unstructured":"Kottemann MC, Smogorzewska A. Fanconi anaemia and the repair of Watson and Crick DNA crosslinks. Nature, 2013, 493: 356-363.","journal-title":"Nature"},{"key":"CITATION8","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1002\/jbmr.3546","volume":"33","author":"Mazon M","year":"2018","unstructured":"Mazon M, Julien J, Ung RV, Picard S, Hamoudi D, Tam R, Filiatrault J. Deletion of the Fanconi anemia c gene in mice leads to skeletal anomalies and defective bone mineralization and microarchitecture. J Bone Miner Res, 2018, 33: 2007-2020.","journal-title":"J Bone Miner Res"},{"key":"CITATION9","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1093\/hmg\/9.18.2665","volume":"9","author":"de Winter JP","year":"2000","unstructured":"de Winter JP. The Fanconi anemia protein FANCF forms a nuclear complex with FANCA, FANCC and FANCG. Hum Mol Genet, 2000, 9: 2665-2674.","journal-title":"Hum Mol Genet"},{"key":"CITATION10","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/35076590","volume":"2","author":"Joenje H","year":"2001","unstructured":"Joenje H, Patel KJ. The emerging genetic and molecular basis of Fanconi anaemia. Nat Rev Genet, 2001, 2: 446-458.","journal-title":"Nat Rev Genet"},{"key":"CITATION11","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1038\/nrg2159","volume":"8","author":"Wang W","year":"2007","unstructured":"Wang W. Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins. Nat Rev Genet, 2007, 8: 735-748.","journal-title":"Nat Rev Genet"},{"key":"CITATION12","doi-asserted-by":"publisher","first-page":"D447","DOI":"10.1093\/nar\/gku1003","volume":"43","author":"Szklarczyk D","year":"2015","unstructured":"Szklarczyk D, Franceschini A, Wyder S, Forslund K, Heller D, Huerta-Cepas J, Simonovic M. STRING v10: protein-protein interaction networks, integrated over the tree of life. Nucleic Acids Res, 2015, 43: D447-D452.","journal-title":"Nucleic Acids Res"},{"key":"CITATION13","doi-asserted-by":"publisher","first-page":"W216","DOI":"10.1093\/nar\/gkac194","volume":"50","author":"Sherman BT","year":"2022","unstructured":"Sherman BT, Hao M, Qiu J, Jiao X, Baseler MW, Lane HC, Imamichi T. DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update). Nucleic Acids Res, 2022, 50: W216-W221.","journal-title":"Nucleic Acids Res"},{"key":"CITATION14","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1038\/bjc.2015.114","volume":"112","author":"Sun S","year":"2015","unstructured":"Sun S, Liang X, Zhang X, Liu T, Shi Q, Song Y, Jiang Y. Phosphoglycerate kinase-1 is a predictor of poor survival and a novel prognostic biomarker of chemoresistance to paclitaxel treatment in breast cancer. Br J Cancer, 2015, 112: 1332-1339.","journal-title":"Br J Cancer"},{"key":"CITATION15","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1002\/ame2.12111","volume":"3","author":"MacArthur Clark JA","year":"2020","unstructured":"MacArthur Clark JA, Sun D. Guidelines for the ethical review of laboratory animal welfare People\u2019s Republic of China National Standard GB\/T 35892\u20102018 [Issued 6 February 2018 Effective from 1 September 2018]. Anim Model Exp Med, 2020, 3: 103-113.","journal-title":"Anim Model Exp Med"},{"key":"CITATION16","doi-asserted-by":"publisher","first-page":"109881","DOI":"10.1016\/j.cbi.2022.109881","volume":"358","author":"Gurung SK","year":"2022","unstructured":"Gurung SK, Kumari S, Dana S, Mandal K, Sen S, Mukhopadhyay P, Mondal N. DNA damage, cell cycle perturbation and cell death by naphthalene diimide derivative in gastric cancer cells. Chem Biol Interact, 2022, 358:","journal-title":"Chem Biol Interact"},{"key":"CITATION17","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1159\/000346035","volume":"4","author":"Alter BP","year":"2013","unstructured":"Alter BP, Rosenberg PS. Vacterl-h association and Fanconi anemia. Mol Syndromol, 2013, 4: 87-93.","journal-title":"Mol Syndromol"},{"key":"CITATION18","doi-asserted-by":"publisher","first-page":"3759","DOI":"10.1182\/blood-2010-08-299917","volume":"117","author":"Castella M","year":"2011","unstructured":"Castella M, Pujol R, Call\u00e9n E, Trujillo JP, Casado JA, Gille H, Lach FP. Origin, functional role, and clinical impact of Fanconi anemia FANCA mutations. Blood, 2011, 117: 3759-3769.","journal-title":"Blood"},{"key":"CITATION19","doi-asserted-by":"publisher","first-page":"a005595","DOI":"10.1101\/mcs.a005595","volume":"6","author":"Lach FP","year":"2020","unstructured":"Lach FP, Singh S, Rickman KA, Ruiz PD, Noonan RJ, Hymes KB, DeLacure MD. Esophageal cancer as initial presentation of Fanconi anemia in patients with a hypomorphic                          FANCA variant. Cold Spring Harb Mol Case Stud, 2020, 6:","journal-title":"Cold Spring Harb Mol Case Stud"},{"key":"CITATION20","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/nature03482","volume":"434","author":"Bartkova J","year":"2005","unstructured":"Bartkova J, Ho\u0159ej\u0161\u00ed Z, Koed K, Kr\u00e4mer A, Tort F, Zieger K, Guldberg P. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature, 2005, 434: 864-870.","journal-title":"Nature"},{"key":"CITATION21","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nrc2602","volume":"9","author":"Malumbres M","year":"2009","unstructured":"Malumbres M, Barbacid M. Cell cycle, CDKs and cancer: a changing paradigm. Nat Rev Cancer, 2009, 9: 153-166.","journal-title":"Nat Rev Cancer"},{"key":"CITATION22","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"Hanahan D","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell, 2011, 144: 646-674.","journal-title":"Cell"},{"key":"CITATION23","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s00281-016-0574-0","volume":"38","author":"Mori M","year":"2016","unstructured":"Mori M, Bogdan A, Balassa T, Csabai T, Szekeres-Bartho J. The decidua-the maternal bed embracing the embryo-maintains the pregnancy. Semin Immunopathol, 2016, 38: 635-649.","journal-title":"Semin Immunopathol"},{"key":"CITATION24","doi-asserted-by":"publisher","first-page":"e142547","DOI":"10.1172\/jci.insight.142547","volume":"6","author":"Kato S","year":"2021","unstructured":"Kato S, Okamura R, Adashek JJ, Khalid N, Lee S, Nguyen V, Sicklick JK. Targeting G1\/S phase cell-cycle genomic alterations and accompanying co-alterations with individualized CDK4\/6 inhibitor\u2013based regimens. JCI Insight, 2021, 6:","journal-title":"JCI Insight"},{"key":"CITATION25","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.ejmech.2019.01.003","volume":"164","author":"Cheng W","year":"2019","unstructured":"Cheng W, Yang Z, Wang S, Li Y, Wei H, Tian X, Kan Q. Recent development of CDK inhibitors: an overview of CDK\/inhibitor co-crystal structures. Eur J Med Chem, 2019, 164: 615-639.","journal-title":"Eur J Med Chem"},{"key":"CITATION26","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s40265-020-01461-2","volume":"81","author":"Braal CL","year":"2021","unstructured":"Braal CL, Jongbloed EM, Wilting SM, Mathijssen RHJ, Koolen SLW, Jager A. Inhibiting cdk4\/6 in breast cancer with palbociclib, ribociclib, and abemaciclib: similarities and differences. Drugs, 2021, 81: 317-331.","journal-title":"Drugs"},{"key":"CITATION27","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41419-022-05528-8","volume":"14","author":"Zhao W","year":"2023","unstructured":"Zhao W, Zhang L, Zhang Y, Jiang Z, Lu H, Xie Y, Han W. The CDK inhibitor AT7519 inhibits human glioblastoma cell growth by inducing apoptosis, pyroptosis and cell cycle arrest. Cell Death Dis, 2023, 14:","journal-title":"Cell Death Dis"},{"key":"CITATION28","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.phrs.2016.03.012","volume":"107","author":"Roskoski Jr R","year":"2016","unstructured":"Roskoski Jr R. Cyclin-dependent protein kinase inhibitors including palbociclib as anticancer drugs. Pharmacol Res, 2016, 107: 249-275.","journal-title":"Pharmacol Res"}],"container-title":["Acta Biochimica et Biophysica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/engine.scichina.com\/doi\/pdf\/40D3609A067544F7BF7A0CCC6C25977F","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/engine.scichina.com\/doi\/10.3724\/abbs.2024045","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/engine.scichina.com\/doi\/pdf\/40D3609A067544F7BF7A0CCC6C25977F","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T08:38:22Z","timestamp":1721810302000},"score":1,"resource":{"primary":{"URL":"https:\/\/engine.scichina.com\/doi\/10.3724\/abbs.2024045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,29]]},"references-count":28,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,4,29]]},"published-print":{"date-parts":[[2024,7,1]]}},"URL":"https:\/\/doi.org\/10.3724\/abbs.2024045","relation":{},"ISSN":["1672-9145"],"issn-type":[{"value":"1672-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4,29]]}}}